9 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
17 Dec 20
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
9:02am
Fortress Biotech
Fortress Biotech, Inc. (Fortress) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
14 Jun 21
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
9:00am
”) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
13 Oct 20
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
6:10am
. (NASDAQ: FBIO). For more information, visit www.avenuetx.com.
About Fortress Biotech
Fortress Biotech, Inc. (“Fortress”) is an innovative
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
12 Mar 19
Avenue Therapeutics Reports Full Year 2018 Financial Results and Recent Corporate Highlights
9:16am
information, visitwww.avenuetx.com.
About Fortress Biotech
Fortress Biotech, Inc. (“Fortress”) (NASDAQ: FBIO) is an innovative biopharmaceutical company
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
13 Nov 23
Avenue Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
4:10pm
, Avenue continued to successfully execute across our pipeline of innovative CNS treatments," said Alexandra MacLean, M.D., Chief Executive Officer
FWP
xd780z42qokqrmr7mork
5 Oct 23
Free writing prospectus
5:05pm
FWP
3m2nkqs r96w1pyppe1d
3 Oct 23
Free writing prospectus
5:47pm
- Prev
- 1
- Next